The TestAVec team will be at the ESGCT between 7-10th October 2025, in Seville, Spain. The annual European congress on cell and gene...

The TestAVec team is pleased to announce that the peer reviewed research article on hingetox has been published in Nature Gene Therapy....

TestAVec researchers, lead by CSO Michael Themis, have just published a paper validating the iPSC derived liver model employed by the...

The annual conference for the BSGCT is coming up, on 20th June at Royal Holloway, University of London. TestAVec's principle scientific...

Professor Mike Themis of Brunel University London – is the holder of a number of patents relating to gene therapy safety, safety testing...